BLINATUMOMAB BRIDGING THERAPY FOR EFFECTIVE MANAGEMENT OF MRD IN PRO-B ALL WITH CNS INVOLVEMENT: A CASE REPORT OF POST TRANSPLANT PATIENT AT 23 MONTHS AFTER ALLOGENIC HEMATOPOIETIC CELL TRANSPLANTATION

Objective: Pro-B ALL is an unusual and highly malignant form of ALL often presenting with CNS involvement. The involvement of the CNS makes the central objective of these treatments that is attaining and maintaining remission more challenging. This is a report of Pro-B ALL of a 52-year old female wh...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Hematology, Transfusion and Cell Therapy
المؤلفون الرئيسيون:	Ceren Dehri Bahşi, Birol Güvenç
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2024-12-01
الموضوعات:	Acute Lymphoblastic Leukemia Pro-B Central Nervous System Involvement Blinatumomab Allogeneic Stem Cell Transplantation Minimal Residual Disease
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2531137924029158